A Study to Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site and Manufactured With the Approved Manufacturing Process at an Alternate Active Pharmaceutical Ingredient Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

Clinical trial NCT03924947 · COMPLETED

Trial details

NCT number: NCT03924947
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2019-10-23
Primary completion: 2022-07-11
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.